IGF-1 LR3 — 1mg | Research Use Only (RUO)

Description

A synthetic long-arginine variant of insulin-like growth factor-1 currently being investigated in controlled laboratory environments for its interaction with IGF receptor signaling and binding protein dynamics.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

IGF-1 LR3 is a modified synthetic analog featuring an arginine substitution at position 3 and a 13-amino acid N-terminal extension. These modifications have been studied in preclinical models for their effect on binding protein interaction and receptor availability. Laboratory research has examined its altered binding characteristics compared to native IGF-1 sequences and its downstream signaling behavior under controlled experimental conditions.

Supplied as a lyophilized powder for analytical and experimental research applications.

PRODUCT SPECIFICATIONS

Compound: IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1)
Quantity: 1 mg per vial
Form: Lyophilized powder
Purity: ≥98%
Storage: -20°C recommended, protect from light
CAS: 946870-92-4

RESEARCH APPLICATIONS

– IGF-1 receptor binding and activation studies
– Binding protein interaction and avoidance research
– Modified vs. native IGF-1 comparative analysis
– Cell proliferation signaling pathway modeling

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes. Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to treat, cure, or prevent any condition. Use is limited to qualified professionals in controlled laboratory environments.

Certificate of Analysis available upon request.